Mismatch Repair Deficiency Cancers
📧 Sign up to get email alerts when something new happens for Mismatch Repair Deficiency Cancers.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor [Phase 2]
A Phase 2 trial evaluating the combination of nivolumab and relatlimab in advanced, microsatellite instability-high cancers that are resista…